CEB, Centre of Biological Engineering, LIBRO - Laboratorio de Investigacao em Biofilmes Rosario Oliveira, University of Minho, 4710-057 Braga, Portugal.
LEPABE, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, s/n, 4200-465 Porto, Portugal.
Curr Med Chem. 2019;26(14):2515-2528. doi: 10.2174/0929867325666180601102333.
Candida is the main human fungal pathogen causing infections (candidiasis), mostly in the elderly and immunocompromised hosts. Even though Candida spp. is a member of the oral microbiota in symbiosis, in some circumstances, it can cause microbial imbalance leading to dysbiosis, resulting in oral diseases. Alternative therapies are urgently needed to treat oral candidiasis (usually associated to biofilms), as several antifungal drugs' activity has been compromised. This has occurred especially due to an increasing occurrence of drugresistant in Candida spp. strains. The overuse of antifungal medications, systemic toxicity, cross-reactivity with other drugs and a presently low number of drug molecules with antifungal activity, have contributed to important clinical limitations. We undertook a structured search of bibliographic databases (PubMed Central, Elsevier's ScienceDirect, SCOPUS and Springer's SpringerLink) for peer-reviewed research literature using a focused review in the areas of alternatives to manage oral candidiasis. The keywords used were "candidiasis", "oral candidiasis", "biofilm + candida", "alternative treatment", "combination therapy + candida" and the reports from the last 10 to 15 years were considered for this review. This review identified several promising new approaches in the treatment of oral candidiasis: combination anti-Candida therapies, denture cleansers, mouth rinses as alternatives for disrupting candidal biofilms, natural compounds (e.g. honey, probiotics, plant extracts and essential oils) and photodynamic therapy. The findings of this review confirm the importance and the urgency of the development of efficacious therapies for oral candidal infections.
念珠菌是引起感染(念珠菌病)的主要人类真菌病原体,主要发生在老年人和免疫功能低下的宿主中。尽管念珠菌属是口腔微生物群落中的共生成员,但在某些情况下,它会导致微生物失衡,导致菌群失调,从而引发口腔疾病。迫切需要替代疗法来治疗口腔念珠菌病(通常与生物膜相关),因为几种抗真菌药物的活性已经受到影响。这种情况尤其发生在念珠菌属菌株的耐药性不断增加的情况下。抗真菌药物的过度使用、全身毒性、与其他药物的交叉反应以及目前具有抗真菌活性的药物分子数量较少,都导致了重要的临床限制。我们在同行评议的研究文献中进行了有针对性的文献检索,在以下领域进行了重点综述:管理口腔念珠菌病的替代方法。使用的关键词是“念珠菌病”、“口腔念珠菌病”、“生物膜+念珠菌”、“替代治疗”、“联合治疗+念珠菌”,并考虑了过去 10 到 15 年的报告。这项综述确定了几种有前途的口腔念珠菌病治疗新方法:联合抗念珠菌治疗、义齿清洁剂、漱口水作为破坏念珠菌生物膜的替代品、天然化合物(如蜂蜜、益生菌、植物提取物和精油)和光动力疗法。本综述的结果证实了开发有效治疗口腔念珠菌感染的重要性和紧迫性。